Author: He, Biao; Fu, Yuhong; Xia, Shuai; Yu, Fei; Wang, Qian; Lu, Lu; Jiang, Shibo
Title: Intranasal application of polyethyleneimine suppresses influenza virus infection in mice Document date: 2016_4_27
ID: 0rg6n7fr_1
Snippet: Emerging and reemerging viruses that cause respiratory infectious diseases, such as severe acute respiratory syndromes coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and influenza viruses, are a significant threat to public health worldwide. Although vaccines are the most effective strategy to prevent viral infection, vaccine development is a long process and may be effective only against the corresponding virus......
Document: Emerging and reemerging viruses that cause respiratory infectious diseases, such as severe acute respiratory syndromes coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and influenza viruses, are a significant threat to public health worldwide. Although vaccines are the most effective strategy to prevent viral infection, vaccine development is a long process and may be effective only against the corresponding virus. Therefore, it is essential to develop antiviral agents for intranasal administration as nonspecific prophylaxis against infection by emerging or reemerging respiratory viruses with epidemic or pandemic potential.
Search related documents:
Co phrase search for related documents- antiviral agent and infectious disease: 1, 2, 3, 4, 5, 6, 7, 8
- antiviral agent and influenza virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39
- antiviral agent and intranasal administration: 1, 2, 3, 4
- antiviral agent and long process: 1
- antiviral agent and pandemic epidemic: 1, 2
- antiviral agent and public health: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26
- antiviral agent and public health significant threat: 1
- antiviral agent and respiratory infectious disease: 1, 2
- antiviral agent and respiratory virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39
- antiviral agent and significant threat: 1, 2
- antiviral agent and vaccine development: 1, 2, 3
- antiviral agent and viral infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41
- correspond virus and infectious disease: 1
- correspond virus and influenza virus: 1
- correspond virus and respiratory virus: 1, 2
- effective strategy and infectious disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43
- effective strategy and influenza virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- effective strategy and intranasal administration: 1, 2, 3, 4
- effective strategy and pandemic epidemic: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date